Effects of metoprolol vs olmesartan medoxomil on microvascular outcomes in patients with stage I-II hypertension

Trial Profile

Effects of metoprolol vs olmesartan medoxomil on microvascular outcomes in patients with stage I-II hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2012

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Metoprolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Nov 2012 New trial record
    • 04 Oct 2012 Results assessing the effects of treatment on systemic microvascular rarefaction presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.
    • 04 Oct 2012 Results assessing the effects of treatment on microvascular endothelial function presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top